Long non-coding RNA is a type of gene that is longer than 200 nt and does not encode protein structural changes. Long non-coding RNA can interact with DNA and mRNA, regulate protein interaction expression, and regulate biological processes.
The global Long Non-coding RNA Sequencing (lncRNA-seq) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the 鈥淟ong Non-coding RNA Sequencing (lncRNA-seq) Industry Forecast鈥� looks at past sales and reviews total world Long Non-coding RNA Sequencing (lncRNA-seq) sales in 2022, providing a comprehensive analysis by region and market sector of projected Long Non-coding RNA Sequencing (lncRNA-seq) sales for 2023 through 2029. With Long Non-coding RNA Sequencing (lncRNA-seq) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long Non-coding RNA Sequencing (lncRNA-seq) industry.
This Insight Report provides a comprehensive analysis of the global Long Non-coding RNA Sequencing (lncRNA-seq) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long Non-coding RNA Sequencing (lncRNA-seq) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Long Non-coding RNA Sequencing (lncRNA-seq) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long Non-coding RNA Sequencing (lncRNA-seq) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long Non-coding RNA Sequencing (lncRNA-seq).
United States market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Long Non-coding RNA Sequencing (lncRNA-seq) players cover Aksomics, Anshengda, BGI, Annuoyouda Gene Technology, LC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Long Non-coding RNA Sequencing (lncRNA-seq) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Equipment Supplies
Service
Segmentation by Application:
Developmental Biology
Oncology
Neuroscience
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Equipment Supplies
Service
Segmentation by Application:
Developmental Biology
Oncology
Neuroscience
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aksomics
Anshengda
BGI
Annuoyouda Gene Technology
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene
Beijing Compson Biotechnology Co., Ltd.
Biomark Biotechnology
BD
10x Genomics
Majorbio
QIAGEN
Roche
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size 2019-2030
2.1.2 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Long Non-coding RNA Sequencing (lncRNA-seq) by Country/Region, 2019, 2023 & 2030
2.2 Long Non-coding RNA Sequencing (lncRNA-seq) Segment by Type
2.2.1 Equipment Supplies
2.2.2 Service
2.3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type
2.3.1 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Market Share by Type (2019-2024)
2.4 Long Non-coding RNA Sequencing (lncRNA-seq) Segment by Application
2.4.1 Developmental Biology
2.4.2 Oncology
2.4.3 Neuroscience
2.4.4 Other
2.5 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application
2.5.1 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Market Share by Application (2019-2024)
3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Player
3.1 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Market Share by Player
3.1.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue by Player (2019-2024)
3.1.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Player (2019-2024)
3.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Long Non-coding RNA Sequencing (lncRNA-seq) by Region
4.1 Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2019-2024)
4.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth (2019-2024)
4.4 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth (2019-2024)
4.5 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth (2019-2024)
4.6 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
5.2 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type (2019-2024)
5.3 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2019-2024)
6.2 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type (2019-2024)
6.3 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
7.2 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type (2019-2024)
7.3 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) by Region (2019-2024)
8.2 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type (2019-2024)
8.3 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Forecast
10.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Region (2025-2030)
10.1.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Region (2025-2030)
10.1.2 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.1.3 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.1.4 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.1.5 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.2 Americas Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Country (2025-2030)
10.2.1 United States Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.2.2 Canada Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.2.3 Mexico Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.2.4 Brazil Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.3 APAC Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Region (2025-2030)
10.3.1 China Long Non-coding RNA Sequencing (lncRNA-seq) Market Forecast
10.3.2 Japan Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.3.3 Korea Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.3.4 Southeast Asia Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.3.5 India Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.3.6 Australia Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.4 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Country (2025-2030)
10.4.1 Germany Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.4.2 France Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.4.3 UK Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.4.4 Italy Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.4.5 Russia Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.5 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Region (2025-2030)
10.5.1 Egypt Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.5.2 South Africa Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.5.3 Israel Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.5.4 Turkey Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
10.6 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Type (2025-2030)
10.7 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Long Non-coding RNA Sequencing (lncRNA-seq) Forecast
11 Key Players Analysis
11.1 Aksomics
11.1.1 Aksomics Company Information
11.1.2 Aksomics Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.1.3 Aksomics Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aksomics Main Business Overview
11.1.5 Aksomics Latest Developments
11.2 Anshengda
11.2.1 Anshengda Company Information
11.2.2 Anshengda Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.2.3 Anshengda Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Anshengda Main Business Overview
11.2.5 Anshengda Latest Developments
11.3 BGI
11.3.1 BGI Company Information
11.3.2 BGI Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.3.3 BGI Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BGI Main Business Overview
11.3.5 BGI Latest Developments
11.4 Annuoyouda Gene Technology
11.4.1 Annuoyouda Gene Technology Company Information
11.4.2 Annuoyouda Gene Technology Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.4.3 Annuoyouda Gene Technology Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Annuoyouda Gene Technology Main Business Overview
11.4.5 Annuoyouda Gene Technology Latest Developments
11.5 LC Sciences
11.5.1 LC Sciences Company Information
11.5.2 LC Sciences Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.5.3 LC Sciences Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 LC Sciences Main Business Overview
11.5.5 LC Sciences Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.6.3 Creative Biolabs Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Information
11.7.2 Eurofins Scientific Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.7.3 Eurofins Scientific Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Eurofins Scientific Main Business Overview
11.7.5 Eurofins Scientific Latest Developments
11.8 CD Genomics
11.8.1 CD Genomics Company Information
11.8.2 CD Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.8.3 CD Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 CD Genomics Main Business Overview
11.8.5 CD Genomics Latest Developments
11.9 Novogene
11.9.1 Novogene Company Information
11.9.2 Novogene Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.9.3 Novogene Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novogene Main Business Overview
11.9.5 Novogene Latest Developments
11.10 Beijing Compson Biotechnology Co., Ltd.
11.10.1 Beijing Compson Biotechnology Co., Ltd. Company Information
11.10.2 Beijing Compson Biotechnology Co., Ltd. Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.10.3 Beijing Compson Biotechnology Co., Ltd. Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beijing Compson Biotechnology Co., Ltd. Main Business Overview
11.10.5 Beijing Compson Biotechnology Co., Ltd. Latest Developments
11.11 Biomark Biotechnology
11.11.1 Biomark Biotechnology Company Information
11.11.2 Biomark Biotechnology Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.11.3 Biomark Biotechnology Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biomark Biotechnology Main Business Overview
11.11.5 Biomark Biotechnology Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.12.3 BD Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 10x Genomics
11.13.1 10x Genomics Company Information
11.13.2 10x Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.13.3 10x Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 10x Genomics Main Business Overview
11.13.5 10x Genomics Latest Developments
11.14 Majorbio
11.14.1 Majorbio Company Information
11.14.2 Majorbio Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.14.3 Majorbio Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Majorbio Main Business Overview
11.14.5 Majorbio Latest Developments
11.15 QIAGEN
11.15.1 QIAGEN Company Information
11.15.2 QIAGEN Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.15.3 QIAGEN Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 QIAGEN Main Business Overview
11.15.5 QIAGEN Latest Developments
11.16 Roche
11.16.1 Roche Company Information
11.16.2 Roche Long Non-coding RNA Sequencing (lncRNA-seq) Product Offered
11.16.3 Roche Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Roche Main Business Overview
11.16.5 Roche Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
